AbbVie Inc., (NYSE:ABBV) a leading healthcare entity listed on S&P 500 Chart index, recently saw a shift in institutional ...

On May 14, the U.S. Food and Drug Administration (FDA) granted accelerated approval to AbbVie's Emrelis (telisotuzumab ...

Over the last 7 days, the United States market has risen by 2.0% and is up 12% over the past year, with earnings forecasted to grow by 14% annually. In such a dynamic environment, identifying high ...

Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the appointment of Greg Chow ...

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

For the quarter, the Voya Corporates Leaders Trust Fund Series B outperformed its benchmark, the S&P 500 Index on a net asset ...

The global market for facial erythema treatments is projected to grow at a CAGR of 5% from 2025 to 2030, driven by several ...

Launched on 01/26/2004, the Vanguard Health Care ETF (VHT) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.

The recent jobs data showed that hiring in healthcare took a big jump in May, as the stock sector has stabilized a bit after ...

The Newport Beach aesthetics company launched Evolysse Form and Evolysse Smooth, which refers to its injectable hyaluronic ...

Most Dividend Kings are currently overpriced, but six offer fair value with high dividend yields. Read more about top picks ...

Vysis, Inc., a leading genomic disease management ... Abbott created the Established Pharmaceuticals Division in 2010. The creation of AbbVie In 2011, Abbott announced it was to separate into ...